Abstract

The liver is a relatively radiosensitive organ. The radiation sensitivity of the liver is to a great extent related to radiation damage of small blood vessels in the liver. Biopsies performed within 2 months after irradiation to dose levels between 30–60 Gy show sinusoidal congestion, hyperemia, loss of central hepatic cells, and vascular changes including loss of endothelium and thickening of intima. Two to four months after irradiation, obliterative changes in efferent veins with collagenous tissue in the lumen are found. After 4 months the specimens reveal fatty vacuolization, vascular changes, centrilobular fibrosis, and atrophy.

Keywords

Toxicity Hepatitis Lymphoma Iodine Oncol 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ingold JA, Reed GB, Kaplan HS, Bagshaw MA (1965) Radiation hepatitis. AJR AM J Roentgenol 93: 200–208Google Scholar
  2. 2.
    Bush RS (1983) Radiation therapy for patients with ovarian cancer. Strahlentherapie 159: 131–137PubMedGoogle Scholar
  3. 3.
    Heimdal K, Hannisdal E, Fossa SD (1988) Survival after palliative radiotherapy of liver metastases. A search for prognostic factors. Acta Oncol 27: 63–65PubMedCrossRefGoogle Scholar
  4. 4.
    Prasad B, Lee MS, Hendrickson FR (1977) Irradiation of hepatic metastases. Int J Radiat Oncol Biol Phys 2: 129–132PubMedCrossRefGoogle Scholar
  5. 5.
    Vigner H (1985) Radiothérapie des cancers secondaires du foie. Ann Gastroenterol Hepatol (Paris) 21: 83–85Google Scholar
  6. 6.
    Burton MA, Gray BN, Jones C, Coletti A (1989) Intraoperative dosimetry of 90Y in liver tissue. Int J Rad Appl Instrum [B] 16: 495–498CrossRefGoogle Scholar
  7. 7.
    Houle S, Yip TK, Shepherd FA, Rotstein LE, Sniderman KW, Theis E, Cawthorn RH, Richmond-Cox K (1989) Hepatocellular carcinoma: pilot trial of treatment with Y-90 microspheres. Radiology 172: 857–860PubMedGoogle Scholar
  8. 8.
    Bretagne JF, Raoul JL, Bourguet P, Duvauferrier R, Deugnier Y, Faroux R, Ramee A, Herry JY, Gastard J (1988) Hepatic artery injection of I-131-labeled Lipiodol. II. Preliminary results of therapeutic use in patients with hepatocellular carcinoma and liver metastases. Radiology 168: 547–550PubMedGoogle Scholar
  9. 9.
    Raoul JI, Bretagne JF, Caucanas JP, Pariente EA, Boyer J, Paris JC et al. (1992) Internal radiation therapy for hepatocellular carcinoma. Results of a French multicenter phase II trial of transarterial injection of iodine 131-labeled Lipiodol. Cancer 69: 346–352PubMedCrossRefGoogle Scholar
  10. 10.
    Mach JP, Bischof-Delaloye A, Curchod S, Studer A, Grob JP, Volant JC, Mosimann F, Givel JC, Douglas P, Leyvraz S et al. (1987) L’immunoscintigraphie par les anticorps monoclonaux radiomarqués. Evolution d’une méthode de diagnostic du cancer et espoir d’une nouvelle forme de thérapie. Schweiz Med Wochenschr 117: 1076–1086PubMedGoogle Scholar
  11. 11.
    Müller-Gartner HW, Montz R, Klapdor R, Hirschmann M, Rehpenning W, Langkowski J (1988) Radioimmunbehandlung solitärer Lebermetastasen mittels intratumoraler Instillation 131J-markierter monoklonaler Antikörper—erste Ergebnisse einer klinischen Studie. Nuklearmedizin 27: 258–265PubMedGoogle Scholar
  12. 12.
    Barone RM, Calabro-Jones P, Thomas TN et al. (1981) Surgical adjuvant therapy in colon carcinoma: a human tumor spheroid model for evaluating radiation sensitizing agents. Cancer 47: 2349–2357PubMedCrossRefGoogle Scholar
  13. 13.
    Moertel DG, Childs PS, Reitmeier PJ et al. (1969) Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 2: 865–867PubMedCrossRefGoogle Scholar
  14. 14.
    Webber BM, Soderberg CH, Leone LA et al. (1978) A combined treatment approach to management of hepatic metastases. Cancer 42: 1087–1095PubMedCrossRefGoogle Scholar
  15. 15.
    Wiley AL Jr, Wirtanen GW, Stephenson JA, Ramirez G, Demets D, Lee JW (1989) Combined hepatic artery 5-fluorouracil and irradiation of liver metastases. A randomized study. Cancer 64: 1783–1789PubMedCrossRefGoogle Scholar
  16. 16.
    Raju PI, Maruama Y, De Simone P, MacDonald J (1987) Treatment of liver metastases with a combination of chemotherapy and hyperfractionated external radiation therapy. Am J Clin Oncol 10: 41–43PubMedCrossRefGoogle Scholar
  17. 17.
    Gansl RC, Hippolito J, Cutait R et al. (1986) Treatment of liver metastatic colorectal carcinoma with sequential methotrexate (MTX), fluorouracil (5-FU), and external hepatic radiation. Proc Am Soc Clin Oncol 5: 94Google Scholar
  18. 18.
    Friedman MA, Cassidy MJ, Levine M et al. (1979) Combined modality therapy of hepatic metastases. Cancer 44: 906–913PubMedCrossRefGoogle Scholar
  19. 19.
    Stillwagon GB, Order SE, Guse C, Klein JL, Leichner PK, Leibel SA, Fishman EK (1989) 194 hepatocellular cancers treated by radiation and chemotherapy combinations: toxicity and response: a Radiation Therapy Oncology Group study. Int J Radiat Oncol Biol Phys 17: 1223–1229PubMedCrossRefGoogle Scholar
  20. 20.
    Yoshikawa M, Ebara M, Ohto M, Miyoshi T (1990) A combination treatment of transcatheter arterial embolization (TAE) and irradiation for hepatocellular carcinoma (HCC) — evaluation for therapeutic efficacy in comparison with TAE or irradiation alone. Nippon Shokakibyo Gakkai Zasshi 87: 225–234PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • Henri-Marcel Hoogewoud
    • 1
  1. 1.Cantonal HospitalFribourgSwitzerland

Personalised recommendations